Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 42, S13–S28 (2019).

Article  Google Scholar 

Shamseddeen, H., Getty, J. Z., Hamdallah, I. N. & Ali, M. R. Epidemiology and economic impact of obesity and type 2 diabetes. Surg. Clin. North. Am. 91, 1163–1172 (2011).

PubMed  Article  Google Scholar 

Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).

PubMed  Article  Google Scholar 

DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Prim. 1, 15019 (2015).

PubMed  Article  Google Scholar 

Huang, E. S. Management of diabetes mellitus in older people with comorbidities. BMJ 353, i2200 (2016).

PubMed  PubMed Central  Article  Google Scholar 

Yang, W. et al. Estimating costs of diabetes complications in people <65 years in the U.S. using panel data. J. Diabetes Complicat. 34, 107735 (2020).

Article  Google Scholar 

Giri, B. et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed. Pharmacother. 107, 306–328 (2018).

CAS  PubMed  Article  Google Scholar 

Paul, S., Ali, A. & Katare, R. Molecular complexities underlying the vascular complications of diabetes mellitus — a comprehensive review. J. Diabetes Complicat. 34, 107613 (2020).

Article  Google Scholar 

Gomez, C. S., Kanagarajah, P. & Gousse, A. E. Bladder dysfunction in patients with diabetes. Curr. Urol. Rep. 12, 419–426 (2011).

PubMed  Article  Google Scholar 

Gandhi, J., Dagur, G., Warren, K., Smith, N. L. & Khan, S. A. Genitourinary complications of diabetes mellitus: an overview of pathogenesis, evaluation, and management. Curr. Diabetes Rev. 13, 498–518 (2017).

PubMed  Google Scholar 

Brown, J. S. et al. Urologic complications of diabetes. Diabetes Care 28, 177–185 (2005).

PubMed  Article  Google Scholar 

Arrellano-Valdez, F., Urrutia-Osorio, M., Arroyo, C. & Soto-Vega, E. A comprehensive review of urologic complications in patients with diabetes. SpringerPlus 3, 549 (2014).

PubMed  PubMed Central  Article  Google Scholar 

Nirmal, J. et al. Functional and molecular characterization of hyposensitive underactive bladder tissue and urine in streptozotocin-induced diabetic rat. PLoS One 9, e102644 (2014).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Palleschi, G. et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J. Urol. 32, 1021–1025 (2014).

PubMed  Article  Google Scholar 

Fayyad, A. M., Hill, S. R. & Jones, G. Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int. Urogynecol. J. Pelvic Floor. Dysfunct. 20, 1339–1344 (2009).

PubMed  Article  Google Scholar 

Qaseem, A. et al. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann. Intern. Med. 168, 569–576 (2018).

PubMed  Article  Google Scholar 

Wang, R., Lefevre, R., Hacker, M. R. & Golen, T. H. Diabetes, glycemic control, and urinary incontinence in women. Female Pelvic Med. Reconstr. Surg. 21, 293–297 (2015).

PubMed  PubMed Central  Article  Google Scholar 

Liu, N. et al. Relationship between blood glucose and hemoglobin A1c Levels and urinary incontinence in women. Int. J. Gen. Med. 14, 4105–4116 (2021).

PubMed  PubMed Central  Article  Google Scholar 

Gulur, D. M., Mevcha, A. M. & Drake, M. J. Nocturia as a manifestation of systemic disease. BJU Int. 107, 702–713 (2011).

PubMed  Article  Google Scholar 

Yoshimura, N., Chancellor, M. B., Andersson, K. E. & Christ, G. J. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 95, 733–738 (2005).

PubMed  Article  Google Scholar 

Fedele, D. Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat. Clin. Pract. Urol. 2, 282–290 (2005). quiz 309.

PubMed  Article  Google Scholar 

Fowler, C. J., Griffiths, D. & de Groat, W. C. The neural control of micturition. Nat. Rev. Neurosci. 9, 453–466 (2008).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lightner, D. J., Gomelsky, A., Souter, L. & Vasavada, S. P. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J. Urol. 202, 558–563 (2019).

PubMed  Article  Google Scholar 

Lee, W. C., Wu, C. C., Wu, H. P. & Tai, T. Y. Lower urinary tract symptoms and uroflowmetry in women with type 2 diabetes mellitus with and without bladder dysfunction. Urology 69, 685–690 (2007).

PubMed  Article  Google Scholar 

Frimodt-Moller, C. Diabetic cystopathy. A review of the urodynamic and clinical features of neurogenic bladder dysfunction in diabetes mellitus. Dan. Med. Bull. 25, 49–60 (1978).

CAS  PubMed  Google Scholar 

Kaplan, S. A., Te, A. E. & Blaivas, J. G. Urodynamic findings in patients with diabetic cystopathy. J. Urol. 153, 342–344 (1995).

CAS  PubMed  Article  Google Scholar 

Harding, C. K. et al. EAU guidelines on management of non-neurogenic female lower urinary tract symptoms (LUTS). (EAU, 2021).

Abraham, N. & Goldman, H. B. An update on the pharmacotherapy for lower urinary tract dysfunction. Expert. Opin. Pharmacother. 16, 79–93 (2015).

CAS  PubMed  Article  Google Scholar 

Kuo, Y.-C. & Kuo, H.-C. Botulinum toxin injection for lower urinary tract dysfunction. Int. J. Urol. 20, 40–55 (2012).

PubMed  Article  CAS  Google Scholar 

Bartley, J., Gilleran, J. & Peters, K. Neuromodulation for overactive bladder. Nat. Rev. Urol. 10, 513–521 (2013).

CAS  PubMed  Article  Google Scholar 

Chancellor, M. B. & Kaufman, J. Case for pharmacotherapy development for underactive bladder. Urology 72, 966–967 (2008).

PubMed  Article  Google Scholar 

Osman, N. I. & Chapple, C. R. Are there pharmacotherapeutic options for underactive bladder? Eur. Urol. Focus. 4, 6–7 (2018).

PubMed  Article  Google Scholar 

Barendrecht, M. M., Oelke, M., Laguna, M. P. & Michel, M. C. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 99, 749–752 (2007).

CAS  PubMed  Article  Google Scholar 

Yuan, Z., Tang, Z., He, C. & Tang, W. Diabetic cystopathy: a review. J. Diabetes 7, 442–447 (2015).

PubMed  Article  Google Scholar 

Andersson, K. E. Oxidative stress and its possible relation to lower urinary tract functional pathology. BJU Int. 121, 527–533 (2018).

PubMed  Article  Google Scholar 

Pizzino, G. et al. Oxidative stress: harms and benefits for human health. Oxid. Med. Cell. Longev. 2017, 8416763 (2017).

PubMed  PubMed Central  Google Scholar 

Lushchak, V. I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 224, 164–175 (2014).

CAS  PubMed  Article  Google Scholar 

Sies, H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 4, 180–183 (2015).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zuo, L., Zhou, T., Pannell, B. K., Ziegler, A. C. & Best, T. M. Biological and physiological role of reactive oxygen species-the good, the bad and the ugly. Acta Physiol. 214, 329–348 (2015).

CAS  Article  Google Scholar 

Zhang, L. et al. Biochemical basis and metabolic interplay of redox regulation. Redox Biol. 26, 101284 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Brand, M. D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 45, 466–472 (2010).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Roberge, S. et al. TNF-α-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes. Cardiovasc. Res. 103, 90–99 (2014).

CAS  PubMed  Article  Google Scholar 

Clauzure, M. et al. Disruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function. PLoS One 9, e99257 (2014).

PubMed  PubMed Central  Article  CAS  Google Scholar 

Sundaresan, M., Yu, Z. X., Ferrans, V. J., Irani, K. & Finkel, T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296–299 (1995).

CAS 

留言 (0)

沒有登入
gif